“There’s room for improvement there, with the 71 percent [of preventing hospitalizations],” he said, noting that he’d like to see the full details of the study. “Data suggest Johnson & Johnson is a very solid vaccine that protects against the delta variant. It may not match up as well against the mRNA vaccine, but we need a lot more data on both of these vaccines.”

Source: Washington Post August 10, 2021 15:16 UTC